MIRA INFORM REPORT

 

 

Report Date :

18.12.2012

 

IDENTIFICATION DETAILS

 

Name :

ACETO FRANCE SAS

 

 

Registered Office :

21 boulevard Delessert Paris, 75016

 

 

Country :

France

 

 

Financials (as on) :

30.06.2011

 

 

Date of Incorporation :

15.01.1957

 

 

Reg. No.:

945750248

 

 

Legal Form :

Public Subsidiary

 

 

Line of Business :

Wholesale trade in speciality chemicals used principally in the pharmaceutical, nutraceutical, agricultural and general chemical industries

 

 

No. of Employees :

14

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

France

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

France - ECONOMIC OVERVIEW

 

France was transitioning from an economy that has featured extensive government ownership and intervention to one that relies more on market mechanisms but is in the midst of a euro-zone crisis. The government has partially or fully privatized many large companies, banks, and insurers, and has ceded stakes in such leading firms as Air France, France Telecom, Renault, and Thales. It maintains a strong presence in some sectors, particularly power, public transport, and defense industries. With at least 75 million foreign tourists per year, France is the most visited country in the world and maintains the third largest income in the world from tourism. France's leaders remain committed to a capitalism in which they maintain social equity by means of laws, tax policies, and social spending that reduce income disparity and the impact of free markets on public health and welfare. France's real GDP contracted 2.6% in 2009, but recovered somewhat in 2010 and 2011. The unemployment rate increased from 7.4% in 2008 to 9.3% in 2010 and 9.1% in 2011. Lower-than-expected growth and increased unemployment have cut government revenues and increased borrowing costs, contributing to a deterioration of France's public finances. The government budget deficit rose sharply from 3.4% of GDP in 2008 to 7.5% of GDP in 2009 before improving to 5.8% of GDP in 2011, while France's public debt rose from 68% of GDP to 86% over the same period. Under President SARKOZY, Paris implemented austerity measures that eliminated tax credits and froze most government spending in an effort to bring the budget deficit under the 3% euro-zone ceiling by 2013 and to highlight France's commitment to fiscal discipline at a time of intense financial market scrutiny of euro-zone debt levels. Socialist Francois HOLLANDE won the May 2012 presidential election, after advocating pro-growth economic policies, as well as measures such as forcing banks to separate their traditional deposit taking and lending activities from more speculative businesses, increasing taxes on bank profits, introducing a new top bracket on income taxes for people earning over €1 million ($1.3 million) a year, and hiring an additional 60,000 civil servants during his five-year term of office.

Source : CIA

Company Name and address

 

ACETO FRANCE SAS              

 

21 boulevard Delessert

Paris, 75016

France

 

Tel:                               +33-0144146940

Fax:                              +33 01 44 14 69 50

 Website:                    www.aceto-europe.com

 

Employees:                   14

Company Type:             Public Subsidiary

Corporate Family:          15 Companies

Ultimate Parent:             Aceto Corporation

           

Incorporation Date:         15-Jan-1957

Financials in:                 USD (In Millions)

             

Fiscal Year End:            30-Jun-2011

Reporting Currency:       Euro

Annual Sales:                33.6

Total Assets:                 15.1

 

 

Business Description

     

 

Wholesale trade in speciality chemicals used principally in the pharmaceutical, nutraceutical, agricultural and general chemical industries

 

 

 

Industry

 

Industry

Chemical Manufacturing

ANZSIC 2006:

3323 - Industrial and Agricultural Chemical Product Wholesaling

NACE 2002:

5155 - Wholesale of chemical products

NAICS 2002:

424690 - Other Chemical and Allied Products Merchant Wholesalers

UK SIC 2003:

5155 - Wholesale of chemical products

UK SIC 2007:

4675 - Wholesale of chemical products

US SIC 1987:

5169 - Chemicals and Allied Products, Not Elsewhere Classified

 

 

Key Executives

 

Name

Title

Urs Habermacher

Président-Directeur Général

Vincent Miata

President

Camille Salfati

Accounts manager, Financial director

Valérie Noireau

Responsable Ventes

Philippe Potelle

General manager

 

 

Registered No.(FRA): 945750248

 

1 - Profit & Loss Item Exchange Rate: USD 1 = EUR 0.7347003
2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.6897265

 

 

Corporate Overview

 

Location
21 boulevard Delessert
Paris, 75016
France

 

Tel:                   +33-0144146940

Fax:                  +33 01 44 14 69 50

 

Website:           www.aceto-europe.com

 

Sales EUR(mil):             24.7

Assets EUR(mil):           10.4

Employees:                   14

Fiscal Year End:            30-Jun-2011

 

Industry:                        Chemical Manufacturing

Incorporation Date:         15-Jan-1957

Company Type:             Public Subsidiary

Quoted Status:              Not Quoted

Previous Name:             Schweizerhall France SA

Registered No.(FRA):     945750248

 

PrĂ©sident-Directeur GĂ©nĂ©ral:          Urs Habermacher

 

 

Industry Codes

 

ANZSIC 2006 Codes:

3323

-

Industrial and Agricultural Chemical Product Wholesaling

 

NACE 2002 Codes:

5155

-

Wholesale of chemical products

 

NAICS 2002 Codes:

424690

-

Other Chemical and Allied Products Merchant Wholesalers

 

US SIC 1987:

5169

-

Chemicals and Allied Products, Not Elsewhere Classified

 

UK SIC 2003:

5155

-

Wholesale of chemical products

 

UK SIC 2007:

4675

-

Wholesale of chemical products

 

 

Business Description

 

Wholesale trade in speciality chemicals used principally in the pharmaceutical, nutraceutical, agricultural and general chemical industries

 

 

More Business Descriptions

Distribute, Market & Sell Specialty Chemicals

 

Aceto France Sas is primarily engaged in wholesale of industrial chemicals (aniline, printing ink, essential oils, industrial gases, chemical glues, colouring matter, synthetic resin, methanol, paraffin, scents and flavourings, soda, industrial salt, acids and sulphur, starch derivatives, etc.); wholesale of fertilisers and agro-chemical products; wholesale of plastic materials in primary forms; and wholesale of rubber.

 

Other Chemical and Allied Products Merchant Wholesalers

 

Financial Data

 

Financials in:

EUR(mil)

1 Year Growth

Revenue:

24.7

36.0%

Assets:

10.4

NA

Current Assets:

10.3

 

Total Liabilities:

10.4

 

Issued Capital:

6.0

 

Net Worth:

8.4

 

Date of Financial Data:

30-Jun-2011

 

 

 

 

Key Corporate Relationships

 

Bank:    Deutsche Bank

 

Corporate Structure News:

 

Aceto France SAS
Total Corporate Family Members: 15

 

Company Name

Company Type

Location

Country

Industry

Sales
(USD mil)

Employees

Aceto Corporation

Parent

Port Washington, NY

United States

Chemical Manufacturing

444.4

233

Aceto Agricultural Chemicals Corp.

Subsidiary

Port Washington, NY

United States

Chemical Manufacturing

 

100

Aceto Pharma (India) Private Ltd.

Subsidiary

Mumbai

India

Biotechnology and Drugs

 

100

Aceto Pharma GmbH

Subsidiary

Hamburg, Hamburg

Germany

Chemical Manufacturing

39.5

40

CDC Products Corp

Subsidiary

Port Washington, NY

United States

Chemical Manufacturing

11.3

35

Aceto France SAS

Subsidiary

Paris

France

Chemical Manufacturing

33.6

14

Aceto Pte Ltd.

Subsidiary

Singapore

Singapore

Chemical Manufacturing

1.0

13

Andrews Paper & Chemical Co

Subsidiary

Port Washington, NY

United States

Paper and Paper Products

 

11

Pharma-Waldhof GmbH

Subsidiary

DĂ¼sseldorf, Nordrhein-Westfalen

Germany

Chemical Manufacturing

 

10

Rising Pharmaceuticals, Inc.

Subsidiary

Allendale, NJ

United States

Biotechnology and Drugs

 

10

Aceto B.V.

Subsidiary

Heemskerk

Netherlands

Chemical Manufacturing

 

7

Aceto FineChem GmbH

Subsidiary

Hamburg, Hamburg

Germany

Chemical Manufacturing

11.4

6

Aceto Pharma Corp

Subsidiary

Port Washington, NY

United States

Biotechnology and Drugs

 

5

Aceto Holding GmbH

Subsidiary

Waldshut

Germany

Chemical Manufacturing

 

2

Aceto Agricultural Chemicals Corporation Ltd.

Subsidiary

Chester

United Kingdom

Nonclassifiable Industries

 

 

 

 

Board of Directors

 

 

Name

Title

Function

Urs Habermacher

 

Président-Directeur Général

Chairman

 

 

Executives

 

Name

Title

Function

Urs Habermacher

 

Président-Directeur Général

Chief Executive Officer

Vincent Miata

 

President

President

René Delmas

 

Directeur Division Pharmacie

Division Head Executive

Philippe Potelle

 

General manager

Administration Executive

Camille Salfati

 

Accounts manager, Financial director

Finance Executive

Valérie Noireau

 

Responsable Ventes

Sales Executive

Guillaume Saint-Clair

 

Responsable Ventes

Sales Executive

Christian Lanez

 

Commercial director

Commercial Executive

 

 

Annual Profit & Loss

 

 

 

 

30-Jun-2011

30-Jun-2010

30-Jun-2009

Period Length

12 Months

12 Months

12 Months

Filed Currency

EUR

EUR

EUR

Exchange Rate (Period Average)

0.7347

0.721483

0.731067

Consolidated

No

No

No

 

 

 

 

Total income

33.8

25.3

26.0

Net sales

33.6

25.2

25.9

Change in stock

-0.6

0.1

1.5

Supplementary operating income

0.2

0.1

0.1

Other operating income

0.0

0.0

0.0

Other external charges

3.0

2.5

2.3

Cost of goods sold

28.5

20.2

19.7

Taxes and social security costs

0.2

0.2

0.1

Social charges

0.5

0.5

0.4

Total payroll costs

1.2

1.0

1.0

Cost of stock depreciation and amortisation

0.2

0.1

0.1

Fixed asset depreciation and amortisation

0.0

0.0

0.0

Other operating costs

0.0

0.0

0.0

Total operating costs

33.0

24.7

25.3

Net operating income

0.8

0.7

0.7

Total financial income

0.1

0.0

0.0

Interest payable on loans

0.0

0.0

0.0

Other expenses

0.1

0.0

0.1

Total expenses

0.1

0.0

0.1

Profit before tax

0.8

0.6

0.7

Extraordinary income

0.1

0.0

0.1

Extraordinary expenses

0.0

0.1

0.0

Extraordinary result

0.1

0.0

0.1

Total taxation

0.3

0.2

0.3

Net profit

0.5

0.4

0.5

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

30-Jun-2011

30-Jun-2010

30-Jun-2009

Filed Currency

EUR

EUR

EUR

Exchange Rate

0.689727

0.816393

0.712936

Consolidated

No

No

No

 

 

 

 

Issued capital

8.7

7.4

8.4

Share premium account

0.0

0.0

0.0

Total reserves

2.5

2.1

0.2

Profits for the year

0.6

0.3

0.5

Profit brought forward from previous year(s)

0.4

-

1.7

Total stockholders equity

12.2

9.8

10.8

Provisions and allowances

0.1

0.1

0.0

Trade creditors

1.9

1.4

0.9

Bank loans and overdrafts

0.0

0.0

0.0

Other loans

-

-

0.0

Other liabilities

0.1

0.0

0.2

Income stated in advance

-

0.0

-

Taxation and social security

0.8

0.5

0.6

Total current liabilities

2.8

2.0

1.6

Total debts

2.8

2.0

1.6

Total liabilities (including net worth)

15.1

11.9

12.5

Patents

0.0

-

0.0

Other fixed assets

0.0

0.0

0.1

Other financial assets

0.0

0.0

0.0

Total non-current assets

0.1

0.1

0.1

Net stocks and work in progress

4.6

3.4

3.9

Trade debtors

8.8

6.2

5.5

Other receivables

0.3

0.2

0.2

Prepaid expenses

0.1

0.1

0.0

Cash and liquid assets

1.3

2.0

1.4

Marketable securities

-

-

1.4

Total current assets

15.0

11.8

12.4

Total assets

15.1

11.9

12.5

 

 

Annual Ratios

 

Financials in: USD (mil)

 

 

 

30-Jun-2011

30-Jun-2010

30-Jun-2009

Period Length

12 Months

12 Months

12 Months

Filed Currency

EUR

EUR

EUR

Exchange Rate

0.689727

0.816393

0.712936

Consolidated

No

No

No

 

 

 

 

Current ratio

5.30

5.90

7.60

Quick ratio

3.70

4.20

5.20

Total liabilities to net worth

0.23%

0.21%

0.15%

Net worth to total assets

0.81%

0.82%

0.87%

Collection period

74.30

84.00

62.70

Stock turnover rate

7.80

6.60

6.80

Asset turnover

2.38%

1.87%

2.13%

Profit margin

0.02%

0.03%

0.03%

Return on assets

0.06%

0.05%

0.05%

Shareholders' return

0.07%

0.06%

0.06%

Sales per employee

13,500.02

9,928.22

-

Profit per employee

318.75

252.64

-

Average wage per employee

471.68

410.70

-

Net worth

12.2

9.8

10.8

Number of employees

12

12

-

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.63

UK Pound

1

Rs.88.40

Euro

1

Rs.71.85

 

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.